World-wide development of antibiotic resistance in pneumococci.
about
Antibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods.Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible.Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance studyIncidence of decreased penicillin sensitivity of Streptococcus pneumoniae from clinical isolatesPneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniaeRelationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistanceA cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogensSusceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.Bacteremic pneumonia caused by penicillin-resistant pneumococci: Case report and review with a Canadian perspectiveIncreased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use.Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice.Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycinβ-Lactam resistance, serotype distribution, and genotypes of meningitis-causing Streptococcus pneumoniae, Rio de Janeiro, Brazil.Pneumococcal resistance to antibiotics.Development of o.a.s.i.s., a new automated blood culture system in which detection is based on measurement of bottle headspace pressure changes.Evaluation of vancomycin for therapy of adult pneumococcal meningitis.Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United StatesCOMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA.Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.The penicillins today.Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin.Activity of amoxicillin-clavulanate against penicillin-resistant Streptococcus pneumoniae in an experimental respiratory infection model in rats.Activities of faropenem, an oral beta-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisPharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations.Treatment of experimental endocarditis due to penicillin-resistant Streptococcus pneumoniae.Targeted synthesis of novel β-lactam antibiotics by laccase-catalyzed reaction of aromatic substrates selected by pre-testing for their antimicrobial and cytotoxic activity.Pneumococcal and Haemophilus influenzae meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns.Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae.Striking differences in the nasopharyngeal flora of healthy Angolan, Brazilian and Dutch children less than 5 years old.Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area.Meningitis due to a multiply resistant pneumococcus.Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis.
P2860
Q33699406-8B9DAEA8-4D0B-46D3-815E-875E74BC8FC4Q33747123-70B60B60-D1C5-421A-8135-F7F15ED0A75FQ33753151-1EE7A9FB-3E9A-4FD7-B645-546C344BE02CQ33839262-A5E4BA8E-C067-46CE-B998-E792FFE85F8DQ33975380-3C57C71E-04CF-4089-9828-3EC3EB5277ABQ33980689-4933EA08-68BC-4631-BE92-C33036CFB081Q34319265-7BA06BFA-5D4A-474A-8683-616CF54328CEQ35123654-5B7C3D09-4821-4E2D-BC04-244F5FBDD98FQ35130268-BA2035CE-F370-4BF6-97E5-4A36C6B38409Q35250729-09246A77-0016-4DB1-BBEC-B77037D2EFFFQ35622545-596D6B70-E870-492B-94F2-BB4DB9AB974DQ35649662-C72727D5-A278-4E17-900A-8CF5180952F2Q35846320-5BA8CC92-44A7-4E54-BD72-8B1B6F04C34BQ35893258-6A43D28D-FDBC-441A-BF91-B4EADCD58E16Q35894130-82398F07-36A0-48D6-8A53-5B7826D10BDFQ36181003-43781749-5801-464C-83CA-FB7C68997E24Q36515266-638A8A71-C5A6-4E35-A53C-FC0680B79864Q36534013-F81B732F-E0E9-4248-8CA4-FE75CEBB7D20Q36557796-4498CA1E-FA1E-4A17-949B-CC0783F3EE4BQ36636190-475C54F6-5D79-4FBF-88A9-968CB112576DQ36723880-98F3DA82-CA66-452B-B6EE-DE094C4BE906Q36757364-9C7214BB-29AE-4603-8A0E-FBDFC5CB7B14Q36757780-9FC93A34-FA6F-42EF-943F-98AC9360244AQ36860798-39E128AE-B7C1-4904-BB05-C693A39FC32AQ36949499-0166B713-A303-4348-B3DD-AF7FF699AB86Q37071655-A30B2BAD-6A5C-4D93-AD17-B0AADCC29880Q37940996-C4476188-1307-4343-BE30-BC8347115BD7Q39477892-6BBEA1BB-2AD1-4FFE-A245-6B2C8A590D60Q39557399-79BD87BC-C3A9-4B58-8948-DCF5D8837061Q39651279-0153553F-FF45-44A1-8415-DC15FEAA1E46Q39671236-8D870D5D-EA1A-41F1-AD2B-4D65A0E78ED6Q39866898-B8A95A1C-035D-4681-A54D-53E77FF5E343Q40828421-6FB264E4-1B08-4860-9106-2A8648379521Q43632796-37081D8F-CCD0-4E1F-A6F7-6FA0B5F7893EQ46162215-AC078BC6-70E4-408F-BEFA-C29488727377Q46829609-A9C6EEA8-4A63-43ED-A0B6-A16A9903A92DQ54075016-B86B76C9-9906-4CCA-871D-C1F4E9988B4FQ54276569-463BF1E2-4173-48F8-A661-487502E29171Q54756488-59074FBF-1F75-4A59-88E2-67BCF950BB21
P2860
World-wide development of antibiotic resistance in pneumococci.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
World-wide development of antibiotic resistance in pneumococci.
@en
World-wide development of antibiotic resistance in pneumococci.
@nl
type
label
World-wide development of antibiotic resistance in pneumococci.
@en
World-wide development of antibiotic resistance in pneumococci.
@nl
prefLabel
World-wide development of antibiotic resistance in pneumococci.
@en
World-wide development of antibiotic resistance in pneumococci.
@nl
P2860
P356
P1476
World-wide development of antibiotic resistance in pneumococci.
@en
P2093
P C Appelbaum
P2860
P304
P356
10.1007/BF02013089
P577
1987-08-01T00:00:00Z